US NEUROLOGY – SUPPLEMENT 3 – 2018

Alice P Mead, Michelle Welborn

In 1998, a British physician named Dr Geoffrey Guy heard the knock of opportunity. Always a visionary, he gathered his unique set of skills and experience, and responded. The events that followed contributed significantly to cannabidiol’s (CBD’s) emergence from relative obscurity into broad public consciousness (personal interview with Guy G, October 31, 2017).1 Dr Guy […]